Analysts See $2.64 EPS for Laboratory Corporation of America Holdings (LH)

April 24, 2018 - By Marguerite Chambers

Laboratory Corporation of America Holdings (NYSE:LH) LogoInvestors sentiment increased to 1.2 in 2017 Q4. Its up 0.30, from 0.9 in 2017Q3. It is positive, as 36 investors sold Laboratory Corporation of America Holdings shares while 209 reduced holdings. 73 funds opened positions while 220 raised stakes. 91.47 million shares or 0.35% less from 91.79 million shares in 2017Q3 were reported.
Argent Co invested in 0.11% or 1,731 shares. Cap Advisors Limited Liability Company reported 0.02% stake. City Tru Communications Fl reported 14,452 shares or 0.92% of all its holdings. 520 were accumulated by Ftb Advsr. Td Asset Mgmt holds 0.01% or 34,307 shares. 38,712 are held by Victory Cap Management Inc. Pension Serv reported 107,904 shares or 0.09% of all its holdings. Moreover, Indiana Trust Inv has 0.1% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 1,366 shares. Veritas Inv Management (Uk) reported 71,143 shares. Iridian Asset Mngmt Limited Com Ct reported 1.62 million shares. Robeco Institutional Asset Mngmt Bv, Netherlands-based fund reported 25,837 shares. Global X Mngmt Llc has 0.02% invested in Laboratory Corporation of America Holdings (NYSE:LH). Fairfield Bush And invested in 2.41% or 54,744 shares. Parkside Retail Bank And accumulated 0% or 74 shares. Nelson Van Denburg & Campbell Wealth Mgmt Gp Limited Liability Co accumulated 0.18% or 5,059 shares.

Since October 30, 2017, it had 0 buys, and 5 insider sales for $10.55 million activity. $149,068 worth of stock was sold by Gilliland Dwight Gary on Monday, October 30. 3,300 Laboratory Corporation of America Holdings (NYSE:LH) shares with value of $548,124 were sold by ANDERSON KERRII B. On Monday, February 12 the insider EISENBERG GLENN A sold $1.41 million. The insider KING DAVID P sold $8.23M.

Analysts expect Laboratory Corporation of America Holdings (NYSE:LH) to report $2.64 EPS on April, 25 before the open.They anticipate $0.42 EPS change or 18.92 % from last quarter’s $2.22 EPS. LH’s profit would be $269.28 million giving it 15.81 P/E if the $2.64 EPS is correct. After having $2.45 EPS previously, Laboratory Corporation of America Holdings’s analysts see 7.76 % EPS growth. The stock increased 0.17% or $0.29 during the last trading session, reaching $166.91. About 71,744 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 14.17% since April 24, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Laboratory Corporation of America Holdings (NYSE:LH) Ratings Coverage

Among 15 analysts covering Laboratory Corp (NYSE:LH), 11 have Buy rating, 0 Sell and 4 Hold. Therefore 73% are positive. Laboratory Corp had 24 analyst reports since October 26, 2017 according to SRatingsIntel. The company was maintained on Thursday, October 26 by Barclays Capital. The firm has “Buy” rating given on Wednesday, January 3 by Canaccord Genuity. The rating was maintained by SunTrust on Thursday, January 11 with “Buy”. The firm has “Buy” rating by Goldman Sachs given on Monday, January 29. The firm has “Overweight” rating given on Wednesday, February 28 by Morgan Stanley. The rating was maintained by Mizuho on Tuesday, February 6 with “Hold”. Barclays Capital maintained Laboratory Corporation of America Holdings (NYSE:LH) rating on Monday, February 26. Barclays Capital has “Overweight” rating and $210 target. Deutsche Bank maintained Laboratory Corporation of America Holdings (NYSE:LH) on Thursday, October 26 with “Buy” rating. The stock of Laboratory Corporation of America Holdings (NYSE:LH) earned “Buy” rating by Craig Hallum on Thursday, October 26. The firm has “Buy” rating by SunTrust given on Wednesday, February 28.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $17.03 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 13.67 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.